Effect of ara-C infusion on clofarabine plasma pharmacokinetics
. | . | Clofarabine, μM; end of infusion . | . | Clofarabine, μM; 6-h sample . | . | ||
---|---|---|---|---|---|---|---|
Patient no. . | Clofarabine, mg/m2 per d . | Day 2 . | Day 6 . | Day 2 . | Day 6 . | ||
1 | 15 | 0.61 | 0.58 | 0.06 | ND | ||
5 | 22.5 | 0.89 | 0.86 | 0.14 | 0.21 | ||
6 | 22.5 | 0.90 | 1.28 | 0.10 | 0.21 | ||
7 | 30 | 1.34 | 2.01 | 0.31 | 0.31 | ||
8 | 30 | ND | 1.39 | 0.13† | 0.17* | ||
9 | 30 | 1.33 | 1.35 | 0.14 | 0.13 | ||
10 | 40 | 2.03 | 1.32 | 0.08 | 0.18 | ||
11 | 40 | 1.28 | 2.55 | 0.23 | 0.20 | ||
12 | 40 | 2.12 | 1.34 | 0.11 | 0.10 |
. | . | Clofarabine, μM; end of infusion . | . | Clofarabine, μM; 6-h sample . | . | ||
---|---|---|---|---|---|---|---|
Patient no. . | Clofarabine, mg/m2 per d . | Day 2 . | Day 6 . | Day 2 . | Day 6 . | ||
1 | 15 | 0.61 | 0.58 | 0.06 | ND | ||
5 | 22.5 | 0.89 | 0.86 | 0.14 | 0.21 | ||
6 | 22.5 | 0.90 | 1.28 | 0.10 | 0.21 | ||
7 | 30 | 1.34 | 2.01 | 0.31 | 0.31 | ||
8 | 30 | ND | 1.39 | 0.13† | 0.17* | ||
9 | 30 | 1.33 | 1.35 | 0.14 | 0.13 | ||
10 | 40 | 2.03 | 1.32 | 0.08 | 0.18 | ||
11 | 40 | 1.28 | 2.55 | 0.23 | 0.20 | ||
12 | 40 | 2.12 | 1.34 | 0.11 | 0.10 |
ND indicates not determined.
A 5-hour sample was used instead of a 6-hour sample.